23 - 24 October, 2017 | Sydney, Australia

Albert Bielinko

Venture and Growth Investor
Telstra Ventures

3:10 PM CORPORATE VENTURING: The Role of Corporate Venture Capital in the Innovation Toolkit

Telstra Ventures has invested more than $350m across 45 technology companies globally, including HealthEngine, Docusign and Box. Telstra has generated more than $200m of revenue for its portfolio companies in the 5+ years it has been investing.

In this session Albert will explore:
  • The role of corporate venture capital
  • Benefits and considerations
  • Why corporations succeed and fail in this space
  • What to look for when investing in start ups
  • Case studies

Check out the incredible speaker line-up to see who will be joining Albert.

Download The Latest Agenda